Elon Musk's Neuralink and UC Davis Accused of Deadly Monkey Experiments

UC Davis and Elon Musk's company Neuralink are facing allegations that researchers mistreated monkeys that were being used to test Neuralink's brain-machine interface technology.

Pandemic Can’t Stop M&A in Orthopedics

Johnson & Johnson’s Depuy Synthes has acquired CrossRoads Extremity Systems from HealpointCapital for an undisclosed sum.

Boston Sci Wraps up Baylis Deal, But Is More M&A on the Way?

The Marlborough, MA-based company hinted at future M&A in an earnings call earlier this month.

More than EUR 1 Billion Raised for Investing in Life Sciences Companies

The LSP 7 fund is expected to finance 15-20 companies developing new drug therapies and medical devices.

RT-PCR Test Identifies Both COVID-19 & Its Variants Within Hours

The recently CE-marked Detectx-Cv+ test can run on standard laboratory equipment without high-end bioinformatics.

ResMed Just Can't Keep up with Demand

Philips' ongoing recall of respiratory devices has created "seemingly infinite demand" for ResMed, but supply chain constraints are holding the company back. Here's what ResMed is doing about it.

FDA Grants Breakthrough Status for New Cancer Tool

The monitoring assay uses optimized algorithms to guide therapy decisions and monitor an individual’s risk of relapse.

The World of Work Is Changing

What do employees need to thrive in this new world? This conversation is trending on LinkedIn among your medical device peers.

Time for a Closer Look at Medtech Salaries & Careers

Our annual salary survey captures the earning power of medtech professionals. Here’s your chance to weigh in on the state of medical device careers and salaries during the Great Resignation.

The Diabetes Tech Revolution Is Real in 2022

Tandem is the latest company to hit a major milestone the diabetes space.

Insulet Raises Diabetes Awareness with Nintendo’s Animal Crossing

Insulet is celebrating representation and inclusion for the diabetes community with Animal Crossing New Horizons.

Masimo Investors May Have Jumped the Gun

Masimo bewildered analysts with its intention to buy consumer tech company Sound United. But did investors 'sound' the alarm too soon?